Ovarian Cancer and the Vague Signs and Symptoms

Article

Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses ovarian cancer and stresses the importance of listening to patients with the vague signs and symptoms of ovarian cancer.

Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses ovarian cancer and stresses the importance of listening to patients with the vague signs and symptoms of ovarian cancer.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.